Legal & General Group PLC Keros Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 31,970 shares of KROS stock, worth $352,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,970
Previous 31,827 0.45%
Holding current value
$352,309
Previous $1.85 Million 72.62%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$15.64 - $70.0 $2,236 - $10,010
143 Added 0.45%
31,970 $506,000
Q2 2024

Aug 14, 2024
BUY
$44.58 - $66.89 $284,063 - $426,223
6,372 Added 25.03%
31,827 $1.45 Million
Q1 2024

Jul 01, 2024
BUY
$41.26 - $70.48 $35,978 - $61,458
872 Added 3.55%
25,455 $1.69 Million
Q1 2024

May 14, 2024
BUY
$41.26 - $70.48 $235,470 - $402,229
5,707 Added 30.23%
24,583 $1.63 Million
Q4 2023

Feb 15, 2024
SELL
$27.12 - $41.05 $1,356 - $2,052
-50 Reduced 0.26%
18,876 $750,000
Q3 2023

Nov 14, 2023
BUY
$31.57 - $43.02 $26,203 - $35,706
830 Added 4.59%
18,926 $603,000
Q2 2023

Aug 14, 2023
BUY
$37.26 - $51.01 $318,535 - $436,084
8,549 Added 89.55%
18,096 $727,000
Q1 2023

May 15, 2023
BUY
$41.44 - $59.32 $60,668 - $86,844
1,464 Added 18.11%
9,547 $407,000
Q4 2022

Feb 14, 2023
BUY
$39.45 - $51.77 $17,436 - $22,882
442 Added 5.78%
8,083 $388,000
Q3 2022

Nov 14, 2022
BUY
$27.8 - $40.12 $20,905 - $30,170
752 Added 10.92%
7,641 $287,000
Q2 2022

Aug 22, 2022
BUY
$26.03 - $67.04 $911 - $2,346
35 Added 0.51%
6,889 $190,000
Q1 2022

May 16, 2022
BUY
$42.12 - $59.36 $29,652 - $41,789
704 Added 11.45%
6,854 $373,000
Q4 2021

Feb 14, 2022
BUY
$36.95 - $62.89 $221 - $377
6 Added 0.1%
6,150 $360,000
Q3 2021

Nov 15, 2021
BUY
$29.27 - $43.71 $73,731 - $110,105
2,519 Added 69.49%
6,144 $243,000
Q2 2021

Aug 12, 2021
BUY
$42.4 - $70.11 $8,861 - $14,652
209 Added 6.12%
3,625 $154,000
Q1 2021

May 17, 2021
SELL
$54.0 - $75.28 $3,456 - $4,817
-64 Reduced 1.84%
3,416 $211,000
Q4 2020

Feb 12, 2021
BUY
$36.0 - $82.74 $95,112 - $218,599
2,642 Added 315.27%
3,480 $245,000
Q3 2020

Nov 13, 2020
SELL
$27.04 - $62.21 $7,841 - $18,040
-290 Reduced 25.71%
838 $32,000
Q2 2020

Aug 14, 2020
BUY
$20.08 - $40.39 $22,650 - $45,559
1,128 New
1,128 $42,000

Others Institutions Holding KROS

# of Institutions
177
Shares Held
31.1M
Call Options Held
646K
Put Options Held
670K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $284M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email